To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Immune Response Testing Market

Immune Response Testing Market Analysis Report By Test Type (Elisa Test, RT-PCR, Rapid Test), By Application (Allergy Testing, HIV Infection, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosis), By End User (Hospital, Diagnostic Centers) - Regional Forecast To 2028

Analysis of Immune Response Testing market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Market Overview

Immune response of the body depends on how it recognizes and protects itself against viruses, bacteria, and substances that are harmful. Advanced diagnostic laboratories use variety of technologies to determine the presence and absence of cell-mediated and antibody-mediated immune response to drugs, toxins, vaccines and pathogens.

Immune response testing measures the response of the immune system to vaccines. Various test are used to diagnose the immune response in individuals. Blood test determines the immune response level in blood and measure the level of blood cells and immune system cells.

Blood test also determines whether the immune system is responding properly and producing antibodies. The immune response testing in laboratories is done with the help of artificial antibodies, which exactly match the substance or germ. Immune response testing contains specific antibodies that bind the substance.

Immune Response Testing Market: Drivers and Restraints

The major factors driving the growth of the market for immune response testing are increasing prevalence of immune-acquired diseases, such as HIV infections. Rising geriatric population and increasing healthcare expenditure are the other factors expected to drive the growth of the market for immune response testing.

Increasing number of research and development activities by the key players is also expected to spur the growth of the market for immune response testing over the forecast period. Likewise, increasing use of immunosuppressant drugs is expected to boost the growth of the immune response testing market.

However, lack of awareness regarding immune response diseases is expected to restrain the growth of the immune response testing market.

Immune Response Testing Market: Overview

The global market for immune response testing is expected to register significant growth over the forecast period due to increasing prevalence of immune response diseases, such as HIV and rheumatoid arthritis. On the basis of test type, Elisa tests segment is expected to dominate the immune response testing market, owing to increasing demand for Elisa testing, its accuracy and specificity.

The rapid test segment is expected to witness high growth during the forecast period owing to its increasing usage, less time for diagnosis and cost effectiveness as compared to other tests. Increasing number of point-of-care testing centers across the globe is expected to fuel the growth of the market for immune response testing over forecast period.

Immune Response Testing Market: Regional Outlook

Geographically, the global immune response testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the leading regional market for immune response testing owing to increasing advancement in the testing and increasing prevalence of immune response diseases.

The immune response testing market in Europe is expected to have second large share due improved infrastructure and use of handy POC diagnostic testing. The Asia Pacific excluding Japan is expected to witness fast growth than the other regions due to large patient population, increasing awareness and initiatives taken by the governments regarding immune response disease.

Japan is expected to account moderate growth in the immune response testing market owing to increasing geriatric population. Latin America and Middle East & Africa are expected to have slow growth over the forecast period.

Don't Need a Global Report?

Save 40% on Country & Region specific reports

Immune Response Testing Market: Key Players

The global immune response testing market is highly fragmented owing to the presence of a large number of manufacturers. Examples of some of the key players operating in the global immune response testing market are

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • EUROIMMUN AG
  • Quest Diagnostics
  • Bio-Rad Laboratories Inc.
  • Charles River
  • Creative Diagnostics

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers an exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
Immune Response Testing Market

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina, Chile, Peru, and Rest of Latin America)
  • Europe [EU -4 (Germany, France, Italy, Spain), BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • APEJ (Greater China, India, S. Korea, ASEAN Countries and Rest of APEJ)
  • Middle East & Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)

Report Highlights:

  • A detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Immune Response Testing Market: Segmentation

Tentatively, the global immune response testing market can be segmented on the basis of test type, application, end user, and geography.

Based on test type, the global immune response testing market is segmented as:

  • Elisa Test
  • RT-PCR
  • Rapid Test
  • Other

Based on the application, the global immune response testing market is segmented as:

  • Allergy Testing
  • HIV infection
  • Cancer
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosis
  • Others

Based on end users, the global immune response testing market is segmented as:

  • Hospital
  • Diagnostic Centers
  • Others

- Premium Report Details -

Immune Response Testing Market

- Let's Connect -

Talk To an Expert Today Connect

- Get Started -

Get insights that lead to new growth opportunities

Pre Book

Get A Special pricing for start-ups and universities

Enquiry Before Buying

- Humble, Yet Honored -

Our prestigious clients

- Research Methodology -

An Adaptive Approach to Modern-day Research Needs

Get Methodology

- FAQs -

The immune response testing market is expected to register a CAGR of 8% in the forecast period 2018-2028.

Abbott Laboratories, F. Hoffmann-La Roche Ltd, EUROIMMUN AG, Quest Diagnostics, Bio-Rad Laboratories Inc., Charles River, Creative Diagnostics are the key players in the immune response testing market?

North America is expected to possess 45% market share for immune response testing market in the forecast period 2018-2028.

The immune response testing market is worth US$ 63 billion in 2022.

Due to increasing use of immunosuppressant drugs, the immune response testing market expands at a CAGR of 11% by 2032.

Increasing healthcare expenditure provides fresh opportunities in the immune response testing market.

Exclusive Report

Need An Exclusive Report For Your Unique Requirement?

Google translate